Funder
Science and Technology Development Fund (STDF)
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference48 articles.
1. EGF–ERBB signalling: towards the systems level;Citri;Nat. Rev. Mol. Cell Biol.,2006
2. ErbB receptors : directing key signaling networks throughout life;Holbro;Annu. Rev. Pharmacol. Toxicol.,2004
3. Tyrosine kinase blockers: new hope for successful cancer therapy;Pytel;Anticancer. Agents Med. Chem.,2009
4. The erbB family of receptors and their ligands: multiple targets for therapy;Salomon;Signal,2001
5. EGFR antagonists in cancer treatment;Ciardiello;N. Engl. J. Med.,2008
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, synthesis, molecular docking, and evaluation of sulfonyl quinazoline analogues as promising liver cancer drugs;Bioorganic Chemistry;2024-12
2. DFT Calculation, ADME/T and Molecular Docking Approach of Methyl 2-oxo-1,2-dihydrofuro[3,4-d] pyrimidine-3(4H)carboxylate;Journal of the Mexican Chemical Society;2024-06-19
3. Coumarin–furo[2,3-d]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies;RSC Medicinal Chemistry;2024
4. Pd(II)-Catalyzed Three-Component Synthesis of Furo[2,3-d]pyrimidines from β-Ketodinitriles, Boronic Acids, and Aldehydes;Organic Letters;2023-12-13
5. Epidermal growth factor receptor dual-target inhibitors as a novel therapy for cancer: A review;International Journal of Biological Macromolecules;2023-12